<rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:digibug.ugr.es:10481/77347">
      <dc:title>Anxiety, Distress and Stress among Patients with Diabetes during COVID-19 Pandemic: A Systematic Review and Meta-Analysis</dc:title>
      <dc:creator>García Lara, Rubén A.</dc:creator>
      <dc:creator>Gómez Urquiza, Jose Luis</dc:creator>
      <dc:creator>Velando Soriano, Almudena</dc:creator>
      <dc:creator>Granados Bolívar, Monserrat E.</dc:creator>
      <dc:creator>Romero Béjar, José Luis</dc:creator>
      <dc:creator>Suleiman Martos, Nora</dc:creator>
      <dc:subject>Anxiety</dc:subject>
      <dc:subject>COVID-19</dc:subject>
      <dc:subject>Diabetes</dc:subject>
      <dc:subject>Distress</dc:subject>
      <dc:subject>Meta-analysis</dc:subject>
      <dc:subject>Stress</dc:subject>
      <dc:description>The prevalence of mental health disorders has increased during the COVID-19 pandemic.&#xd;
Patients with chronic diseases, such as diabetes, are a particularly vulnerable risk group. This study&#xd;
aims to assess the levels and prevalence of anxiety, distress, and stress in patients with diabetes during&#xd;
the COVID-19 pandemic. A systematic review was conducted in CINAHL, Cochrane, LILACS,&#xd;
Medline, SciELO, and Scopus in accordance with the Preferred Reporting Items for Systematic&#xd;
Reviews and Meta-Analyses (PRISMA) statement. Thirty-seven articles with a total of 13,932 diabetic&#xd;
patients were included. Five meta-analyses were performed. The prevalence of anxiety was&#xd;
23% (95% CI = 19–28) in T1DM and 20% (95% CI = 6–40) in T2DM patients. For diabetes distress&#xd;
it was 41% (95% CI = 24–60) for T1DM and 36% in T2DM patients (95% CI = 2–84). For stress,&#xd;
the prevalence was 79% (95% CI = 49–98) in T1DM patients. People with diabetes have significant&#xd;
psychiatric comorbidity as well as psychological factors that negatively affect disease management,&#xd;
increasing their vulnerability in an emergency situation. To establish comprehensive care in diabetic&#xd;
patients addressing mental health is essential, as well as including specific policy interventions to&#xd;
reduce the potential psychological harm of the COVID-19 pandemic.</dc:description>
      <dc:date>2022-10-17T08:17:40Z</dc:date>
      <dc:date>2022-10-17T08:17:40Z</dc:date>
      <dc:date>2022-08-30</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>García-Lara, R.A... [et al.]. Anxiety, Distress and Stress among Patients with Diabetes during COVID-19 Pandemic: A Systematic Review and Meta-Analysis. J. Pers. Med. 2022, 12, 1412. [https://doi.org/10.3390/jpm12091412]</dc:identifier>
      <dc:identifier>https://hdl.handle.net/10481/77347</dc:identifier>
      <dc:identifier>10.3390/jpm12091412</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Atribución 4.0 Internacional</dc:rights>
      <dc:publisher>MDPI</dc:publisher>
   </ow:Publication>
</rdf:RDF>